Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
90.00
-1.31 (-1.43%)
Sep 10, 2026, 1:47 PM EDT - Market open

Hinge Health Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Hinge Health stock has a consensus rating of "Buy" and an average price target of $107.73. The average 1-year stock price forecast is 19.70% higher than the current stock price, while the lowest is $85 (-5.56%) and the highest is $140 (+55.56%).

Price Target: $107.73 (+19.70%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$85$107.73$105$140
Change-5.56%+19.70%+16.67%+55.56%

Analyst Ratings

The average analyst rating for Hinge Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy888888
Buy777777
Hold111111
Sell000000
Strong Sell000000
Total161616161616

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$96$115
BuyMaintains$96$115+27.78%Sep 8, 2026
Morgan Stanley
Morgan Stanley
Buy
Maintains
$117
BuyMaintains$117+30.00%Aug 25, 2026
Truist Financial
Truist Financial
Buy
Reiterates
$85$112
BuyReiterates$85$112+24.44%Aug 11, 2026
RBC Capital
RBC Capital
Buy
Maintains
$75$110
BuyMaintains$75$110+22.22%Aug 5, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Reiterates
$100$105
BuyReiterates$100$105+16.67%Aug 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
859.29M
from 587.86M
Increased by 46.17%
Revenue Next Year
1.09B
from 859.29M
Increased by 26.51%
EPS This Year
2.40
from 2.62
Decreased by -8.35%
EPS Next Year
3.06
from 2.40
Increased by 27.32%
Fiscal YearFY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
292.73M390.40M587.86M859.29M
Revenue Growth
-33.37%50.58%46.17%
Gross Profit
194.18M300.59M469.30M737.06M
Gross Margin
66.33%77.00%79.83%85.78%
Operating Income
-130.51M-31.22M-546.37M240.94M
Net Income
-108.14M-11.93M-528.26M162.05M
EPS
--2.622.40
EPS Growth
----8.35%
Forward PE
--30.3237.48
Free Cash Flow
-68.94M406.80M298.53M
No. Analysts
---15
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High872.5M
Avg859.3M
Low856.2M

Revenue Growth

Revenue Growth202620272028
High
48.4%
Avg
46.2%
Low
45.7%

EPS Forecast

EPS202620272028
High3.39
Avg2.40
Low2.24

EPS Growth

EPS Growth202620272028
High
29.4%
Avg
-8.3%
Low
-14.5%